Improving Non-specific Immunity to Coronavirus Disease (COVID-19) by the Novelty, Diversity, and Quantity of Antigen
نویسندگان
چکیده
منابع مشابه
Obesity and Coronavirus Disease 2019 (COVID-19)
Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection that was first reported on December 31, 2019 in China . This disease behaves variously: from asymptomatic infection to influenza-like symptoms and severe acute respiratory distress syndrome (ARDS) . In the recent months, COVID-19 has infected millions and killed hundre...
متن کاملWorld and the novel coronavirus disease (COVID-19
سخن سردبیر Editorial مجله دانشگاه علوم پزشکی رفسنجان دوره نوزدهم، فروردین 1399، 2-1 جهان و بیماری کرونا ویروس جدید (کووید-19) ) World and the novel coronavirus disease (COVID-19 محسن رضائیان[1]،[2] M.Rezaeian به هنگام تکمیل این سخن سردبیری در بیست و سوم فروردین سال 1399 برابر با یازدهم آوریل سال 2020 میلادی، تقریباً صد روز از گزارش رسمی بیماری جدیدی ...
متن کاملCoronavirus disease 2019 (COVID-19) Immunopathogenesis, Diagnosis, and Treatment
SARS-CoV-2 is a member of the coronaviruses family that causes the outbreak of coronavirus disease 2019 (COVID-19) in China in late 2019 which has exploded to a global pandemic. The reference genome of the SARS-CoV-2 is considered to be very closely related to SARS-CoV and the virus uses the ACE-2 receptor for cellular entry similar to SARS-CoV. The most common symptoms of COVID-19 are fever, c...
متن کاملA Review of Coronavirus Disease-2019 (COVID-19)
There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, China in December 2019. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower ...
متن کاملA Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Public Health
سال: 2020
ISSN: 2296-2565
DOI: 10.3389/fpubh.2020.00393